4.885
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
16.51%
101.00
|
86.69 | 115.18 | 130.23 | 109.98 |
|
26.60%
113.58
|
89.72 | 82.14 | 114.93 | 85.13 |
Benefits Costs and Expenses |
0.32%
112.84
|
112.48 | 109.35 | 144.77 | 114.32 |
Costs And Expenses |
0.32%
112.84
|
112.48 | 109.35 | 144.77 | 114.32 |
Operating Income/Loss |
52.98%
-12.58
|
-26.75 | 6.242 | -13.89 | -3.852 |
Nonoperating Income/Loss |
22.95%
0.742
|
0.963 | -0.419 | -0.648 | -0.491 |
Income/Loss From Continuing Operations Before Tax |
54.10%
-11.83
|
-25.78 | 5.823 | -14.54 | -4.343 |
Income Tax Expense/Benefit, Deferred |
18.96%
-1.026
|
-1.266 | -2.198 | - | - |
Income Tax Expense/Benefit |
64.81%
-2.442
|
-6.94 | -6.508 | 2.503 | -2.243 |
Income/Loss From Continuing Operations After Tax |
50.16%
-9.392
|
-18.84 | 12.33 | -17.04 | -2.10 |
|
50.16%
-9.392
|
-18.84 | 12.33 | -17.04 | -2.10 |
Preferred Stock Dividends And Other Adjustments |
2.81
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.44%
126.85
|
126.30 | 132.58 | 132.57 | 131.86 |
Diluted Average Shares |
0.44%
126.85
|
126.30 | 133.93 | 132.57 | 131.86 |
Basic Earnings Per Share |
41.18%
-0.10
|
-0.17 | 0.09 | -0.13 | -0.02 |
Diluted Earnings Per Share |
41.18%
-0.10
|
-0.17 | 0.09 | -0.13 | -0.02 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
2.81
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):